Gholipour Mahin, Mikaeli Javad, Mowla Seyed Javad, Bakhtiarizadeh Mohammad Reza, Saghaeian Jazi Marie, Javid Naeme, Fazlollahi Narges, Khoshnia Masoud, Behnampour Naser, Moradi Abdolvahab
Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan Iran.
Autoimmune and Motility Disorders Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran Iran.
Turk J Biol. 2021 Jun 23;45(3):262-274. doi: 10.3906/biy-2101-61. eCollection 2021.
Molecular knowledge regarding the primary esophageal achalasia is essential for the early diagnosis and treatment of this neurodegenerative motility disorder. Therefore, there is a need to find the main microRNAs (miRNAs) contributing to the mechanisms of achalasia. This study was conducted to determine some patterns of deregulated miRNAs in achalasia. This case-control study was performed on 52 patients with achalasia and 50 nonachalasia controls. The miRNA expression profiling was conducted on the esophageal tissue samples using the next-generation sequencing (NGS). Differential expression of miRNAs was analyzed by the edgeR software. The selected dysregulated miRNAs were additionally confirmed using the quantitative reverse transcription polymerase chain reaction (qRT-PCR). Fifteen miRNAs were identified that were significantly altered in the tissues of the patients with achalasia. Among them, three miRNAs including miR-133a-5p, miR-143-3p, and miR-6507-5p were upregulated. Also, six miRNAs including miR-215-5p, miR-216a-5p, miR-216b-5p, miR-217, miR-7641 and miR-194-5p were downregulated significantly. The predicted targets for the dysregulated miRNAs showed significant disease-associated pathways like neuronal cell apoptosis, neuromuscular balance, nerve growth factor signaling, and immune response regulation. Further analysis using qRT-PCR showed significant down-regulation of hsa-miR-217 (p-value = 0.004) in achalasia tissue. Our results may serve as a basis for more future functional studies to investigate the role of candidate miRNAs in the etiology of achalasia and their application in the diagnosis and probably treatment of the disease.
关于原发性贲门失弛缓症的分子知识对于这种神经退行性运动障碍的早期诊断和治疗至关重要。因此,有必要找到导致贲门失弛缓症发病机制的主要微小RNA(miRNA)。本研究旨在确定贲门失弛缓症中miRNA失调的一些模式。这项病例对照研究对52例贲门失弛缓症患者和50例非贲门失弛缓症对照进行。使用下一代测序(NGS)对食管组织样本进行miRNA表达谱分析。通过edgeR软件分析miRNA的差异表达。另外使用定量逆转录聚合酶链反应(qRT-PCR)对选定的失调miRNA进行确认。鉴定出15种在贲门失弛缓症患者组织中显著改变的miRNA。其中,包括miR-133a-5p、miR-143-3p和miR-6507-5p在内的三种miRNA上调。此外,包括miR-215-5p、miR-216a-5p、miR-216b-5p、miR-217、miR-7641和miR-194-5p在内的六种miRNA显著下调。失调miRNA的预测靶点显示出与疾病相关的重要途径,如神经元细胞凋亡、神经肌肉平衡、神经生长因子信号传导和免疫反应调节。使用qRT-PCR的进一步分析显示,贲门失弛缓症组织中hsa-miR-217显著下调(p值=0.004)。我们的结果可能为未来更多的功能研究奠定基础,以研究候选miRNA在贲门失弛缓症病因中的作用及其在疾病诊断和可能的治疗中的应用。